DK1214302T3 - Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere - Google Patents

Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere

Info

Publication number
DK1214302T3
DK1214302T3 DK00962346T DK00962346T DK1214302T3 DK 1214302 T3 DK1214302 T3 DK 1214302T3 DK 00962346 T DK00962346 T DK 00962346T DK 00962346 T DK00962346 T DK 00962346T DK 1214302 T3 DK1214302 T3 DK 1214302T3
Authority
DK
Denmark
Prior art keywords
oxadiazol
alkoxy
ones
phenyl
substituted
Prior art date
Application number
DK00962346T
Other languages
Danish (da)
English (en)
Inventor
Stefan Petry
Karl Schoenafinger
Guenter Mueller
Karl-Heinz Baringhaus
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1214302T3 publication Critical patent/DK1214302T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
DK00962346T 1999-09-04 2000-08-22 Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere DK1214302T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19942354A DE19942354A1 (de) 1999-09-04 1999-09-04 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
PCT/EP2000/008150 WO2001017981A1 (de) 1999-09-04 2000-08-22 Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one und ihre verwendung als lipase-hemmer

Publications (1)

Publication Number Publication Date
DK1214302T3 true DK1214302T3 (da) 2004-02-16

Family

ID=7920884

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00962346T DK1214302T3 (da) 1999-09-04 2000-08-22 Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere

Country Status (30)

Country Link
US (1) US6596742B1 (xx)
EP (1) EP1214302B1 (xx)
JP (1) JP2003508522A (xx)
KR (1) KR100723817B1 (xx)
CN (1) CN1152024C (xx)
AR (1) AR032430A1 (xx)
AT (1) ATE253059T1 (xx)
AU (1) AU781330B2 (xx)
BR (1) BR0013765A (xx)
CA (1) CA2383731A1 (xx)
CZ (1) CZ2002772A3 (xx)
DE (2) DE19942354A1 (xx)
DK (1) DK1214302T3 (xx)
EE (1) EE04811B1 (xx)
ES (1) ES2204685T3 (xx)
HK (1) HK1048318B (xx)
HR (1) HRP20020187A2 (xx)
HU (1) HUP0202988A3 (xx)
IL (2) IL148275A0 (xx)
MX (1) MXPA02001834A (xx)
NO (1) NO323129B1 (xx)
NZ (1) NZ517551A (xx)
PL (1) PL197314B1 (xx)
PT (1) PT1214302E (xx)
RU (1) RU2265600C2 (xx)
SK (1) SK285924B6 (xx)
TR (1) TR200200553T2 (xx)
WO (1) WO2001017981A1 (xx)
YU (1) YU10402A (xx)
ZA (1) ZA200201594B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10102265C1 (de) * 2001-01-18 2002-08-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
DE10208986A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase
DE10208987A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
US6900233B2 (en) 2002-02-28 2005-05-31 Aventis Pharma Deutschland Gmbh Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones, pharmaceutical composition and method for treating obesity thereof
DE10247680B4 (de) * 2002-10-12 2005-09-01 Aventis Pharma Deutschland Gmbh Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
US7208504B2 (en) 2002-10-12 2007-04-24 Sanofi-Aventis Deutschland Gmbh Bicyclic inhibitors of hormone sensitive lipase
JP2008515986A (ja) * 2004-10-13 2008-05-15 ワイス Ｎ−ベンゼンスルホニル置換アニリノ−ピリミジン類似物
EP2178821A2 (en) * 2007-07-12 2010-04-28 Deviris Inc. Hormone sensitive lipase modulators and methods of use
JP2011507952A (ja) * 2007-12-27 2011-03-10 バイアル−ポルテラ アンド シーエー，エス．エー． 医療用途用５−ｏ−置換３−ｎ−フェニル−１、３、４−オキサジアゾロン類
AR074978A1 (es) 2008-12-23 2011-03-02 Bial Portela & Ca Sa 3-n-aril-1,3,4-oxadiazolonas 5-o-sustituidas para uso en el tratamiento del dolor y procedimiento de obtencion
US8501768B2 (en) * 2011-05-17 2013-08-06 Hoffmann-La Roche Inc. Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
CN114163351B (zh) * 2020-09-11 2024-01-23 江苏优嘉植物保护有限公司 噁虫酮中间体2-(2-甲氧基)苯肼甲酸甲酯合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB518042A (en) 1937-09-15 1940-02-15 Ljungstroms Angturbin Ab Improvements in elastic fluid turbines of the double rotation type
FR2299028A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Nouvea
FR2299328A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Derives de l'alcoyloxy-5 phenyl-3 oxyde azo
US4076824A (en) 1975-02-03 1978-02-28 Rhone-Poulenc Industries Anthelmintic oxadiazolinone derivatives
DK156439C (da) 1980-09-15 1990-01-22 Shell Int Research 7-substituerede 2,3-dihydrobenzofuranderivater samt pesticidpraeparater indeholdende disse og en fremgangsmaade til bekaempelse af skadelige organismer
DE3267258D1 (en) 1981-06-15 1985-12-12 Shell Int Research 7-substituted 2,3-dihydrobenzofurans, their preparation and their use as pesticides or as chemical intermediates
JPS60115502A (ja) * 1983-11-28 1985-06-22 Mitsubishi Chem Ind Ltd 殺虫剤
US5236939A (en) 1989-09-23 1993-08-17 Bayer Aktiengesellschaft Substituted 1,3,4-oxa(thia)diazolinones process for their preparation and their use of combating endoparasites
DE3931843A1 (de) 1989-09-23 1991-04-04 Bayer Ag Substituierte 1,3,4-oxa(thia)diazolinone verfahren zu ihrer herstellung und ihre verwendung der bekaempfung von endoparasiten
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents

Also Published As

Publication number Publication date
DE50004274D1 (de) 2003-12-04
CA2383731A1 (en) 2001-03-15
NO20021007D0 (no) 2002-02-28
MXPA02001834A (es) 2002-08-12
CN1152024C (zh) 2004-06-02
DE19942354A1 (de) 2001-03-08
AU781330B2 (en) 2005-05-19
HRP20020187A2 (en) 2004-02-29
KR20020024336A (ko) 2002-03-29
HK1048318B (zh) 2004-12-10
TR200200553T2 (tr) 2002-06-21
JP2003508522A (ja) 2003-03-04
PL197314B1 (pl) 2008-03-31
EP1214302A1 (de) 2002-06-19
ATE253059T1 (de) 2003-11-15
WO2001017981A1 (de) 2001-03-15
YU10402A (sh) 2004-11-25
CN1371369A (zh) 2002-09-25
IL148275A0 (en) 2002-09-12
EE200200109A (et) 2003-06-16
NO20021007L (no) 2002-02-28
BR0013765A (pt) 2002-04-30
SK285924B6 (sk) 2007-11-02
ZA200201594B (en) 2003-04-30
HUP0202988A3 (en) 2004-12-28
RU2265600C2 (ru) 2005-12-10
ES2204685T3 (es) 2004-05-01
HK1048318A1 (en) 2003-03-28
PL353214A1 (en) 2003-11-03
NZ517551A (en) 2003-10-31
US6596742B1 (en) 2003-07-22
IL148275A (en) 2008-08-07
CZ2002772A3 (cs) 2002-05-15
AU7411200A (en) 2001-04-10
AR032430A1 (es) 2003-11-12
SK3012002A3 (en) 2002-06-04
EE04811B1 (et) 2007-04-16
HUP0202988A2 (hu) 2002-12-28
NO323129B1 (no) 2007-01-08
PT1214302E (pt) 2004-03-31
KR100723817B1 (ko) 2007-06-04
EP1214302B1 (de) 2003-10-29

Similar Documents

Publication Publication Date Title
DK1133477T3 (da) Substituerede benzimidazoler og deres anvendelse som parpinhibitorer
NO20021449L (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse
NO20013452D0 (no) Benzoheterocykler og deres anvendelse som MEK-inhibitorer
NO991922L (no) Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer
DK1198454T3 (da) Multilinderivater og deres anvendelse som antibakterielle midler
DK1244647T3 (da) Quinzolinderivater som VIGF-inhibitorer
NO20026010D0 (no) Substituerte quinazolinderivater og deres anvendelse som inhibitorer
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
NO20021253L (no) Kinolylpropylpiperidinderivater og deres anvendelse som antibakterielle midler
NO20021239L (no) Pteridinoner som kinase-inhibitorer
DK1246802T3 (da) 4-aminopicolinater og deres anvendelse som herbicider
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
NO992492D0 (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
NO20015065D0 (no) Pyrazolobenzodiazepiner som CDK2-inhibitorer
NO20014603L (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
NO20004550D0 (no) Enzyminhibitorer
NO20025357L (no) Antranylamider og deres anvendelse som legemidler
DK0989121T3 (da) Substituerede benzamider og deres anvendelse som immunmodulatorer
NO20024201D0 (no) Substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-on og anvendelse derav for hemning av hormonsensitiv lipase
PT1171440E (pt) 3-ciano-¬1,7|,¬1,5|, e ¬1,8|-naftiridinas substituidas inibidoras de tirosina quinases
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
DK1214302T3 (da) Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere
DK1150996T3 (da) Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer
DE60024101D1 (de) Enzyminhibitoren